Use of a low-molecular weight heparinoid (danaparoid-sodium) for continuous renal replacement therapy in intensive care patients. - Lindhoff-Last,E.; Betz,C.; Bauersachs,R. (Clin Appl Thrombosis/Hemostasis, 2001)